Scillarenin
![]() | |
| Names | |
|---|---|
| IUPAC name
5-[(3S,8R,9S,10R,13R,14S,17R)-3,14-Dihydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one | |
Other names
| |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C24H32O4 | |
| Molar mass | 384.516 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Scillarenin is a steroidal aglycone belonging to the bufadienolide class of cardiac glycosides. It represents the non-sugar core of several naturally occurring cardiac glycosides found in plants such as Scilla and Drimia maritima.
Chemistry and natural occurrence
Scillarenin is a steroid derivative with a cyclopenta[a]phenanthrene nucleus and a characteristic unsaturated lactone ring at the C-17 position, a defining feature of bufadienolides. It serves as the aglycone component released upon hydrolysis of glycosidic cardiac compounds, such as scillaren A.[1]
The compound is not typically found in free form in plants but occurs as part of glycosidic cardiac toxins.[2]
Scillarenin itself has comparatively low intrinsic biological activity, while its glycosylated derivatives act as potent inhibitors of Na+/K+-ATPase, producing cardiotonic and toxic effects. These properties are characteristic of bufadienolide cardiac glycosides rather than the free aglycone.[3]
References
- ↑ Krenn, L.; Jambrits, M.; Kopp, B. (1988). "Bufadienolides from Urginea species and related plants". Planta Medica. 54 (3): 227–232. doi:10.1055/s-2006-962412. PMID 17265257.
- ↑ Kamano, Yoshiaki; Pettit, George (1974-08-01). "Bufadienolides. 26. Synthesis of Scillarenin". Journal of Organic Chemistry. 39 (17): 2629–2631. doi:10.1021/jo00931a041. ISSN 0022-3263. PMID 4412259. Retrieved 2026-06-27.
- ↑ "Scillarenin Substance Record".
